Biomarker ID | 1153 |
PMID | 23824564 |
Year | 2013 |
Biomarker | 5,6-dihydrouracil +choline phosphate+ glycerol + methylpalmitate |
Biomarker Basis | Concentration Based |
Biomolecule | Metabolites |
Source | Tissue |
Subjects | Humans |
Regulation | Differentially Expressed |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | Organ Confined Vs Non Orgnan Confined |
Type of Biomarker | Prognostic |
Cohort | 260 patients with Prostate cancer such that 67 had organ Confined Disease and 193 had Non Organ Confined Disease |
Senstivity | NA |
Specificity | NA |
AUC | 0.62 |
Accuracy | NA |
Level Of Significance | p<0.05 |
Method Used | gas chromatography-mass spectrometry (GC–MS) |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on independent patient dataset |
Technical Name | NA |